Akorn names new CEO

Akorn Inc. has named Douglas S. Boothe as its new president and CEO, effective Jan. 1, 2019, the company announced in a press release.
“I am excited and humbled with the opportunity to lead Akorn and our dedicated employees as we focus our energies toward expanding our offerings to customers, improving our financial performance and enhancing long-term shareholder value,” Boothe said in the release.
Boothe previously served as president of the generics division of Impax Laboratories, a developer and manufacturer of bioequivalent pharmaceuticals, and as executive vice president and

Full Story →